Braskem (NYSE:BAK) Stock, Quote.Headers.trade-ideas

Braskem

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

Movers

News

Intraday Update

Markets

Trading Ideas

AIOT

APLT

BLCO

GYRE

IAUX

LUNR

TERN

VSCO

Applied Therapeutics, PowerFleet, VF Corp, Victoria&#39;s Secret And Other Big Stocks Moving Higher On Wednesday

Spirit_Airlines-Wikimedia Commons

ALLG

AMGN

BOWL

CRML

CVAC

EYPT

GERN

IART

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

SAVE

UNIT

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday

Wall Street

AESI

BCRX

MARA

OCGN

PACB

PRFT

SLQT

SNDL

TRUP

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday&#39;s Mid-Day Session

Braskem SA

Roadside Real Estate PLC

BakeryToken - United States Dollar

Global Oil & Gas Ltd

Condor Energy Ltd

BAKER GLOBAL ASSET MGMT by Baker Global Asset Management Inc.

Baker Global Asset Management Inc

WIIM

Braskem shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $7.7 to $10.

U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Wednesday.
Shares of Applied Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) rose sharply during Wednesday's session after the FDA communicated that an advisory committee meeting would <a href="https://www.benzinga.com/quote/APLT">no longer be required.</a>
Applied Therapeutics shares jumped 72% to $8.00 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) shares surged 52% to $8.19 after the company announced it was awarded a NASA Near Space Network contract for communication and navigation services, with a maximum potential value of $4.82 billion.</li>
<li>PowerFleet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>) gained 13% to $5.26 after the company announced it entered into a definitive agreement for the acquisition of Fleet Complete for $200 million.</li>
<li>Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) surged 7.5% to $19.96.</li>
<li>Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) gained 7.5% to $7.43. UBS analyst Luiz Carvalho upgraded Braskem from Neutral to Buy and raised the price target from $7.7 to $10.</li>
<li>i-80 Gold Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#NASDAQ">IAUX</a>) jumped 7.5% to $1.15. The company announced the appointment of Richard Young as CEO.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TERN#NASDAQ">TERN</a>) gained 7% to $10.31.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) surged 6.9% to $19.67. Barclays analyst Adrienne Yih upgraded VF from Equal-Weight to Overweight and raised the price target from $19 to $22.</li>
<li>Gannett Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCI#NYSE">GCI</a>) gained 6.6% to $5.83.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GYRE#NASDAQ">GYRE</a>) surged 6.1% to $14.89.</li>
<li>Victoria&#8217;s Secret &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) rose 5.9% to $25.71. Barclays analyst Adrienne Yih upgraded Victoria&#8217;s Secret from Underweight to Equal-Weight and raised the price target from $23 to $25.  </li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) gained 4.6% to $117.55.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40917630/how-to-earn-500-a-month-from-darden-restaurants-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Darden Restaurants Stock Ahead Of Q1 Earnings</a></li>
</ul>

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday

UBS analyst Luiz Carvalho upgrades Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) from Neutral to Buy and raises the price target from $7.7 to $10.

Upgrades

Price Target

Analyst Ratings

UBS Upgrades Braskem to Buy, Raises Price Target to $10

Braskem SA shares are trading lower after JP Morgan lowered its price target on the stock from $10 to $9.5.

JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) with a Neutral and lowers the price target from $10 to $9.5.

JP Morgan Maintains Neutral on Braskem, Lowers Price Target to $9.5

Citigroup analyst Gabriel Barra upgrades Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) from Neutral to Buy.

Citigroup Upgrades Braskem to Buy

JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) with a Neutral and lowers the price target from $11 to $10.

JP Morgan Maintains Neutral on Braskem, Lowers Price Target to $10

Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) reported $3.618 billion in sales this quarter. This is a 3.34 percent decrease over sales of $3.743 billion the same period last year.

Earnings

Braskem Q1 Sales $3.618B Down From $3.743B YoY, Net Loss $273M Down From Net Income $35M YoY

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.
Shares of Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) fell sharply during Monday's session as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion. Adjusted EPS loss was $(1.46), down from $(0.82), <a href="https://www.benzinga.com/quote/SAVE/earnings">missing the consensus of $(1.45).</a>
Spirit Airlines shares dipped 9.8% to $3.3450 on Monday.
Here are some other big stocks recording losses in today's session.
<ul>
<li>EyePoint Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) shares fell 37.7% to $12.29 after the company&#8217;s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.</li>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) shares tumbled 17.8% to $23.76 following weak second-quarter EPS guidance.</li>
<li>Bowlero Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) declined 16.7% to $10.40 in pre-market trading after posting weaker-than-expected quarterly results.</li>
<li>Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) shares dipped 15.5% to $7.63 in pre-market trading after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) declined 15.2% to $13.97 after the stock rose more than 40% last week.</li>
<li>Uniti Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) declined 11.5% to $3.9489 after the company announced plans for a $300 million offering of 10.50% Senior Secured Notes due 2028 by its subsidiaries.</li>
<li>TreeHouse Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) tumbled 10.3% to $33.41 after the company reported mixed first-quarter financial results including a net sales decline.</li>
<li>Jasper Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) dipped 9.2% to $22.28. HC Wainwright &amp; Co. analyst Emily Bodnar initiated coverage on Jasper Therapeutics with a Buy rating and announced a price target of $65.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) declined 7.9% to $9.18.</li>
<li>Medical Properties Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) declined 8% to $4.48 after tenant Steward Health Care reportedly filed for bankruptcy protection.</li>
<li>Tyson Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) fell 7.8% to $57.18 following weak quarterly sales.</li>
<li>Allego N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLG#NASDAQ">ALLG</a>) declined 7.8% to $1.1799.</li>
<li>CureVac N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) fell 7.1% to $2.9080.</li>
<li>Titan International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) declined 6.7% to $9.36.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) fell 3.8% to $3.78.</li>
<li>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) fell 3.8% to $299.53.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38646096/bitcoin-ethereum-move-lower-akash-network-becomes-top-loser">Bitcoin, Ethereum Move Lower; Akash Network Becomes Top Loser</a>

Shares of Perficient, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFT#NASDAQ">PRFT</a>) shares rose sharply during Monday's session after the company disclosed an acquisition deal and <a href="https://www.benzinga.com/quote/PRFT/earnings">first-quarter FY24 results</a>.
The company stated that it has entered into a definitive deal to be acquired by an affiliate of BPEA Private Equity Fund VIII (EQT Asia), part of EQT AB in an all-cash transaction at an enterprise value of around $3.0 billion.
Perficient shares jumped 53% to $73.60 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) gained 19% to $5.30 following strong first-quarter results.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 15% to $2.1050.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) gained 13.2% to $19.83.</li>
<li>Trupanion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) rose 10.9% to $22.02. The company recently reported first-quarter financial results.</li>
<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) surged 10.9% to $1.4750. Ocugen is expected to host conference call on Tuesday, May 14 to discuss business updates and first quarter 2024 financial results.</li>
<li>SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares gained 10.5% to $2.5999.</li>
<li>SelectQuote, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) jumped 10.3% to $2.25. SelectQuote is expected to Release fiscal third quarter 2024 earnings on May 9.</li>
<li>Lotus Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) gained 9.4% to $7.80.</li>
<li>Atlas Energy Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NASDAQ">AESI</a>) rose 7.7% to $23.65, reversing from earlier weakness after reporting first-quarter results. The company also raised its dividend.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>EyePoint Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) dipped 37.7% to $12.29 after the company&#8217;s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.</li>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) shares dropped 17.8% to $23.76 following weak second-quarter EPS guidance.</li>
<li>Bowlero Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) fell 16.7% to $10.40 in pre-market trading after posting weaker-than-expected quarterly results.</li>
<li>Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) shares declined 15.5% to $7.63 in pre-market trading after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) fell 15.2% to $13.97 after the stock rose more than 40% last week.</li>
<li>Uniti Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) fell 11.5% to $3.9489 after the company announced plans for a $300 million offering of 10.50% Senior Secured Notes due 2028 by its subsidiaries.</li>
<li>TreeHouse Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) dipped 10.3% to $33.41 after the company reported mixed first-quarter financial results including a net sales decline.</li>
<li>Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) declined 9.8% to $3.3450 as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) fell 7.9% to $9.18.</li>
<li>Tyson Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) fell 7.8% to $57.18 following weak quarterly sales.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38641042/how-to-earn-500-a-month-from-fmc-stock-ahead-of-q1-earnings">How To Earn $500 A Month From FMC Stock Ahead Of Q1 Earnings</a>

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session

Braskem shares are trading lower after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.

The performance of the U.S. corporate bond market in the first quarter of the year was generally flat, though there were notable distinctions between the high-grade <a href="https://www.benzinga.com/money/high-yield-bonds">and high-yield sectors. </a>
Bonds issued by companies with higher credit ratings (BBB and above) experienced a slight downward trajectory, as showed by the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQD#NYSE">LQD</a>). Conversely, lower-rated companies boasting higher yields showed modestly positive performance, as indicated by the iShares iBoxx $ High Yield Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYG#NYSE">HYG</a>).
Also Read: <a href="https://www.benzinga.com/news/large-cap/24/04/38098774/top-10-us-high-yield-corporate-bonds-with-returns-over-20-in-april-2024">Top 10 US High-Yield Corporate Bonds With Returns Over 20% In April 2024</a>
Below is a list of U.S. corporate bonds that have exhibited the strongest performance in the last three months.
<h3 class="wp-block-heading">10) Macy&#8217;s Retail Holdings LLC 4.3% 12/43</h3>
<ul>
<li>Issuer: Macy&#8217;s Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>)</li>
<li>ISIN: US55616XAJ63</li>
<li>Last price: $82.08</li>
<li>Yield to maturity (%): 5.9712</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 15.83%</li>
</ul>
<h3 class="wp-block-heading">9) Ally Financial Inc. 4.7%</h3>
<ul>
<li>Issuer: Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>)</li>
<li>ISIN: US02005NBN93</li>
<li>Last price: $78.174</li>
<li>Type: subordinated</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 16.91%</li>
</ul>
<h3 class="wp-block-heading">8) Lincoln National Corp. 7.938% 06/66</h3>
<ul>
<li>Issuer: Lincoln National Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>)</li>
<li>ISIN: US534187AS84</li>
<li>Last price: $74.73</li>
<li>Maturity: 17/05/2066</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 17.87%</li>
</ul>
<h3 class="wp-block-heading">7) Carvana Co. 5.875% 20/28</h3>
<ul>
<li>Issuer: Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>)</li>
<li>ISIN: USU1468GAD61</li>
<li>Last price: $65.00</li>
<li>Yield to maturity (%): 18.1963</li>
<li>Maturity: 01/10/2028</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 20.37%</li>
</ul>
<h3 class="wp-block-heading">6) Braskem America Finance Co. 7.125% 11/41</h3>
<ul>
<li>Issuer: Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)</li>
<li>ISIN: USU1065PAA94</li>
<li>Last price: $90.85</li>
<li>Yield to maturity (%): 8.2834</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $200,000</li>
<li>3-month performance: 20.5%</li>
</ul>
<h3 class="wp-block-heading">5) M.D.C. Holdings Inc. 3.966% 21/61</h3>
<ul>
<li>Issuer: M.D.C. Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDC#NYSE">MDC</a>)</li>
<li>ISIN: US55616XAJ63</li>
<li>Last price: $82.08</li>
<li>Yield to maturity (%): 5.9712</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 23.53%</li>
</ul>
<h3 class="wp-block-heading">4) QVC Inc. 5.95% 13/43</h3>
<ul>
<li>Issuer: QVC Inc.</li>
<li>ISIN: US747262AM52</li>
<li>Last price: $64.53</li>
<li>Yield to maturity (%): 10.4849</li>
<li>Maturity: 15/03/2043</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 23.76%</li>
</ul>
<h3 class="wp-block-heading">3) At Home Group Inc. 4.875% 21/28</h3>
<ul>
<li>Issuer: At Home Group Inc.</li>
<li>ISIN: USU04798AA90</li>
<li>Last price: $47.61</li>
<li>Yield to maturity (%): 27.4573</li>
<li>Maturity: 15/07/2028</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 26.38%</li>
</ul>
<h3 class="wp-block-heading">2) Lumen Technologies Inc. 4.5% 20/29</h3>
<ul>
<li>Issuer: Lumen Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>)</li>
<li>ISIN: USU1566PAD79</li>
<li>Last price: $36.32</li>
<li>Yield to maturity (%): 33.1453</li>
<li>Maturity: 15/01/2029</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 27.01%</li>
</ul>
<h2 class="wp-block-heading">Chart: Lumen Technologies Bond Outperforms Lumen Shares In 2024</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1024x495.png" alt="" class="wp-image-277973" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">1) Beyond Meat Inc. 0.000% 21/27</h3>
<ul>
<li>Issuer: Beyond Meat Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>)</li>
<li>ISIN: US08862EAB56</li>
<li>Last price: $23.87</li>
<li>Maturity: 15/03/2027</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 28.08%</li>
</ul>
<h2 class="wp-block-heading">Chart: Beyond Meat Bonds Outperform Shares In 2024</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1024x495.png" alt="" class="wp-image-277986" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Why Have Beyond Meat Bonds Outperformed Shares?</h2>
Beyond Meat reported higher than expected revenue in the fourth quarter of 2023, yet suffered larger losses than anticipated. Following the earnings announcement, the company committed to significantly cutting costs and enhancing manufacturing efficiency. 
These efforts improved the outlook on the company&#8217;s ability to fulfill its debt obligations, boosting investor confidence in Beyond Meat&#8217;s survival prospects, rather than reflecting a true turnaround in its long-term profitability.
Following its earnings report, Beyond Meat saw an initial market enthusiasm with rises in both bonds and shares. However, while bond values maintained their upward trajectory, the stock&#8217;s gains quickly dissipated, reversing the post-earnings uplift. 
Since the beginning of the year, Beyond Meat&#8217;s zero-coupon bond, due to mature in March 2027, has seen a notable increase of 28%, contrasting with a roughly 6% drop in the company&#8217;s share price.
Read now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38091433/ai-revolution-is-underway-yet-its-economic-impact-is-several-years-off-goldman-sach">AI Revolution Is Underway, Yet Its Economic Impact Is &#8216;Several Years Off&#8217;: Goldman Sachs</a>
Image generated using artificial intelligence via Midjourney.

Fintech news covering the emerging Financial Technology services sector

Fintech

Large Cap

Mid Cap

Bonds

Specialty ETFs

Small Cap

ETFs

ALLY

BYND

CVNA

LUMN

Top 10 US Corporate Bonds By Market Performance In 2024: April Update

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.
Shares of Sportradar Group AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srad#NASDAQ">SRAD</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million <a href="https://www.benzinga.com/quote/SRAD/earnings">share repurchase program</a>.
Sportradar posted quarterly earnings of 8 cents per share, beating market estimates of 4 cents per share. The company&rsquo;s quarterly sales came in at $271.88 million, beating market expectations of $271.46 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Sportradar Group shares jumped 10.7% to $11.17 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Annovis Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NASDAQ">ANVS</a>) shares surged 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer&#39;s disease, with Topline efficacy data expected in April.</li>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) gained 23% to $2.7650 after the company reported a year-over-year increase in FY23 EPS results.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) climbed 18.1% to $43.00.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) rose 18% to $2.0297 amid a rise in Bitcoin.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) jumped 16.7% to $3.7600 after the company reported a fourth-quarter fiscal 2023 revenue of $242.6 million, marginally beating the consensus of $242.4 million.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) climbed 16.5% to $31.70.</li>
<li>Braskem S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bak#NYSE">BAK</a>) climbed 12.7% to $10.13 after the company on Tuesday reported fourth-quarter financial results.</li>
<li>LiveWire Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lvwr#NYSE">LVWR</a>) surged 12.5% to $7.29.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) gained 12.4% to $10.25.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) climbed 12.3% to $56.55 after the company announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation achieved a &#39;positive predictive outcome&#39; and will conclude enrollment earlier than anticipated.</li>
<li>Topgolf Callaway Brands Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modg#NYSE">MODG</a>) rose 11.8% to $16.11 following a Chosun Daily report suggesting the company is up for sale.</li>
<li>Alight, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alit#NASDAQ">ALIT</a>) gained 11.5% to $9.85 after the company announced an agreement to sell its Payroll &amp; Professional Services business for up to $1.2 billion.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 10.5% to $6.00.</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) climbed 9.3% to $4.3050.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) rose 7.5% to $17.72.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 7.5% to $20.77 amid a rise in Bitcoin.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) climbed 6.8% to $23.92.</li>
<li>Spirit AeroSystems Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spr#NYSE">SPR</a>) rose 6.7% to $35.19.</li>
<li>Carvana Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) climbed 5.3% to $83.07.</li>
<li>Chipotle Mexican Grill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmg#NYSE">CMG</a>) gained 5.1% to $2,941.41 after company&#39;s board approved a 50-for-1 split of common shares.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37839587/disney-jpmorgan-and-more-cnbcs-final-trades"> Disney, JPMorgan And More: CNBC&#39;s &#39;Final Trades&#39;</a>

Penny Stocks

ALIT

ANVS

CLSK

DRCT

DWAC

IBRX

LIVN

LVWR

MODG

SKIN

SRAD

TSHA

WULF

Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday

Braskem shares are trading higher after the company on Tuesday reported Q4 financial results.

Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) reported its Q4 earnings results on Tuesday, March 19, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Braskem missed estimated earnings by -45.0%, reporting an EPS of $-0.8 versus an estimate of $-0.55.
Revenue was down $244.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.2 which was followed by a 0.0% increase in the share price the next day.

To track all earnings releases for Braskem <a href="https://www.benzinga.com/quote/BAK/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Braskem Q4 Earnings

Braskem shares are trading higher after the company reported Q4 financial results.

BRASKEM S.A.&nbsp;((B3: BRKM3, BRKM5 and BRKM6, NYSE:<a href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>, LATIBEX: XBRK)) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 4Q23 Earnings Release.
4Q23 HIGHLIGHTS&nbsp;
CONSOLIDATED
<ul>
<li>Recurring EBITDA of US$ 211 MM, around R$1,049 million. Higher than 3Q23 (+US$23 million) and 4Q22 (+US$243 million).</li>
<li>Cash position&nbsp;of US$ 3.6 billion, ensuring coverage of debt maturities over the next 72 months.</li>
<li>Cost reduction: Reduction of ~23% in general and administrative expenses, compared to 4Q22. Approximately R$186 MM as a result of fixed cost reduction initiatives.</li>
<li>PE Production – Mexico: Utilization Rate of 84%, +18 p.p. vs. 3Q23 and +15 p.p. vs. 4Q22. Consistent feedstock supply.</li>
</ul>
The full earnings release is available on the Company's IR website: <a href="http://www.braskem-ri.com.br/en">www.braskem-ri.com.br/en</a>
Braskem will host conference calls to discuss its Results Tuesday, March 19 at 11:00 a.m. US ET.

Braskem Posts Q4 Recurring EBITDA Of $211M, Up 13% From QoQ; Cash Position Of $3.6B, Ensuring Coverage Of Debt Maturities Over The Next 72 Months

Grant Award will Fund an Innovative New Pathway for Multi-layer Plastic Packaging Circularity
RD&amp;D Partnership Project includes Braskem America, University of Massachusetts Lowell, Dow Chemical, and Aquapak
One of three REMADE awards recently granted to Braskem
Braskem ((B3: BRKM3, BRKM5 and BRKM6, NYSE:<a href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>, LATIBEX: XBRK)) ("Company"), the largest polyolefins producer in the Americas and leading producer of biopolymers in the world, today announced its polymer recycling technology research partnership has been awarded a $671,000 Research, Demonstration, and Development (RD&amp;D) grant from the Reducing Embodied Energy and Decreasing Emissions (REMADE) Institute, a public-private partnership established by the United States Department of Energy (DOE). The winning RD&amp;D project is focused on new advanced manufacturing technology to produce sustainable and recyclable multilayer plastic films with outstanding properties for challenging applications. The project is a partnership between Braskem America, the University of Massachusetts Lowell, Dow Chemical, and Aquapak, all of which are providing additional foundational project funding. REMADE is the first institute in the U.S. dedicated to accelerating the nation's transition to a Circular Economy.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20231120148246/en/">https://www.businesswire.com/news/home/20231120148246/en/</a>
"Braskem is honored to have been selected among this partnership of incredibly talented innovators who are all committed to having a positive impact on our planet and our industry," said Amanda Zani, Technology Platform Manager, Braskem. "As a leading producer of advanced polymer solutions in the United States, with a commitment to significantly expanding the availability of sustainably focused offerings, Braskem firmly believes that this project has incredible potential for advancing our commitment to a more circular economy, which also includes Design for Recycling technology."
Braskem RD&amp;D Partnership Project Awarded Funding by REMADE:
Remaking of Recyclable Multilayer Barrier Films
<ul>
<li>This research project seeks to develop new technologies such as a unique poly(vinyl alcohol) (PVOH) polymer, ultrasound-assisted extrusion, and water-based material separation to create high-performance films that are easily separable. In collaboration with material suppliers, the University of Massachusetts Lowell aims to reduce packaging material consumption and bolster recycling efforts. The two-year project's deliverables include processing protocols for recyclable films and separation methods via aqueous dissolution. This project positions to reshape the packaging industry's economic landscape by facilitating 100% material recovery.</li>
</ul>
Meg Sobkowicz Kline, University of Massachusetts Lowell Professor in the Plastics Engineering Department commented, "Our advanced film processing and recovery approach will enable low-cost separation and recovery of film components for more circular packaging. We are excited to work with Braskem and other industry partners to deliver these high-barrier multilayer films with inherent recycling advantages. It is critical that major materials suppliers and converters support and participate in this research so that innovations can be rapidly translated to industry."
The project is well aligned with Braskem's ambition to expand its portfolio to include 300,000 tons of thermoplastic resins and chemicals with recycled content by 2025 and 1 million tons of such products by 2030. In addition, Braskem seeks to reduce greenhouse gas emissions in scopes 1 and 2 by 15% in 2030 and achieve carbon neutrality by 2050.
The REMADE Institute enables the early-stage applied research and development of key industrial platform technologies that could dramatically reduce the embodied energy and carbon emissions associated with industrial-scale materials production and processing. By focusing its efforts on the technical and economic barriers that prevent greater material recycling, recovery, remanufacturing, and reuse, the REMADE Institute seeks to motivate industry investments to advance technology development and support the U.S. manufacturing eco-system. The U.S. Department of Energy and REMADE selected 14 projects in October 2023 with a combined total of $9.8 million in research and development funding. Since the Institute's founding in 2017, REMADE has launched or selected nearly 100 R&amp;D projects, representing a total combined value of nearly $100 million.
The circular economy is a sustainable model that aims to minimize waste by keeping resources in use for as long as possible, extracting their maximum value while in use, and then recovering and regenerating products and materials at the end of a resource's life cycle. Not only does this reduce environmental impact, but it also offers new business opportunities and economic benefits, supporting innovation, job creation, and global competitiveness.
REMADE funded research projects seek to innovate industrial-scale materials production and processing, achieving multiple positive impacts among the following Target Technical Performance Metrics (TPMs), including:
<ul>
<li>Reducing primary feedstock consumed</li>
<li>Reducing secondary feedstock energy</li>
<li>Increasing embodied energy efficiency</li>
<li>Reducing greenhouse gas (GHG) emissions</li>
<li>Facilitating cross-industry reuse</li>
<li>Balancing cost and energy party</li>
</ul>
According to the U.S. Department of Energy, manufacturing accounts for 25% of U.S. energy consumption at a cost of approximately $150 billion. Based on data from the U.S. Environmental Protection Agency, industry is the single largest contributor to greenhouse gas emissions in the nation, at 30%. By embracing the circular economy, REMADE's investments ensure that America's manufacturing sector remains globally competitive while moving the nation closer to meeting the clean energy goals set forth by the Biden-Harris Administration including achieving a net-zero-emissions economy by 2050.
Detailed information on all REMADE projects can be found at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.remadeinstitute.org&amp;esheet=53837844&amp;newsitemid=20231120148246&amp;lan=en-US&amp;anchor=www.remadeinstitute.org&amp;index=1&amp;md5=99494f83c1ee18ce328c1d02b8022abb">www.remadeinstitute.org</a>.
ABOUT REMADE
Founded in 2017, REMADE is a 167-member public-private partnership established and funded in part by the U.S. Department of Energy's Office of Advanced Materials and Manufacturing Technologies (AMMTO) with an initial investment of $140 million. REMADE is the only national institute focused entirely on developing innovative technologies to accelerate the U.S.'s transition to a Circular Economy. In partnership with industry, academia, trade organizations, and national laboratories, REMADE enables early-stage applied research and development that will create jobs, dramatically reduce embodied energy and greenhouse gas emissions, and increase the supply and use of recycled materials. For more information about REMADE (Reducing EMbodied Energy And Decreasing Emissions), visit <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.remadeinstitute.org&amp;esheet=53837844&amp;newsitemid=20231120148246&amp;lan=en-US&amp;anchor=www.remadeinstitute.org&amp;index=2&amp;md5=3667eeeaec9fcef1ccac73c09cc2deab">www.remadeinstitute.org</a>.

Contracts

Braskem Announces $671,000 REMADE Institute Grant Award For Advanced Manufacturing Of Sustainable And Recyclable Multilayer Plastic Films

<h3>Gainers</h3>
<ul>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) shares climbed 83.5% to $0.4169 after reporting first-quarter results.</li>
<li>Astra Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) shares climbed 59.5% to $1.18 after the company announced it received a non-binding proposal from founders Chris Kemp and Adam London offering to acquire all of the outstanding common stock of the company not currently owned by Kemp and London.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpst#NASDAQ">TPST</a>) gained 50% to $4.22 following third-quarter results.</li>
<li>Virgin Galactic Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spce#NYSE">SPCE</a>) surged 27.5% to $1.99 after the company reported better-than-expected third-quarter financial results.</li>
<li>The Honest Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hnst#NASDAQ">HNST</a>) gained 23% to $1.4780 following upbeat quarterly results.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) rose 22.7% to $26.70 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>Infinera Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infn#NASDAQ">INFN</a>) gained 22.6% to $4.06 following preliminary third-quarter results..</li>
<li>JanOne Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jan#NASDAQ">JAN</a>) shares climbed 22.4% to $0.3936 as gaining over 7% on Wednesday.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 22% to $10.43 on the heels of the company&#39;s quarterly results.</li>
<li>SomaLogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slgc#NASDAQ">SLGC</a>) rose 21.3% to $2.4750 following strong quarterly results.</li>
<li>PubMatic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pubm#NASDAQ">PUBM</a>) shares climbed 20.4% to $14.57 after the company reported better-than-expected third-quarter financial results.</li>
<li>LiveRamp Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ramp#NYSE">RAMP</a>) rose 19.4% to $35.83 after the company posted upbeat second-quarter results and issued strong sales forecast.</li>
<li>OncoCyte Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) gained 18.5% to $2.55 following third-quarter results.</li>
<li>Braskem S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bak#NYSE">BAK</a>) shares rose 17.8% to $8.28 after Valor Economico Reported that Abu Dhabi&#39;s Adnoc Made a new offer to acquire a stake in the Brazilian petrochemical producer. Braskem also reported results for the third quarter.</li>
<li>Calumet Specialty Products Partners, L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clmt#NASDAQ">CLMT</a>) surged 16.3% to $15.12 following third-quarter results.</li>
<li>Seritage Growth Properties (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/srg#NYSE">SRG</a>) gained 16.3% to $8.65 following third-quarter results.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 16.1% to $11.94.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) gained 15.4% to $11.57 after the company reported better-than-expected third-quarter financial results.</li>
<li>Jackson Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jxn#NYSE">JXN</a>) climbed 14.4% to $44.55 following strong earnings.</li>
<li>Bakkt Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkkt#NYSE">BKKT</a>) shares rose 14.2% to $0.7326 after declining 29% on Wednesday.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) gained 13.2% to $0.3225.</li>
<li>Carrols Restaurant Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tast#NASDAQ">TAST</a>) gained 10.8% to $6.90 after the company reported better-than-expected third-quarter financial results.</li>
<li>Globavend Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gvh#NASDAQ">GVH</a>) shares climbed 10.4% to $2.8501. Globavend Holdings recently announced pricing of $6 million initial public offering of 1.5 million shares of common stock at a price of $4 per share.</li>
<li>The Walt Disney Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) rose 6.2% to $89.74 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Tapestry, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpr#NYSE">TPR</a>) gained 6.2% to $29.17 following upbeat earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) tumbled 75.3% to $0.9501 following third-quarter results. Enviva named Glenn Nunziata as interim Chief Executive Officer in addition to his CFO role.</li>
<li>ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) fell 69.4% to $0.0711.</li>
<li>Atara Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atra#NASDAQ">ATRA</a>) dipped 67% to $0.40 after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint of confirmed disability improvement (CDI) by expanded disability status scale (EDSS) at 12 months compared to placebo.</li>
<li>Ikena Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikna#NASDAQ">IKNA</a>) declined 61% to $1.5768 following weak sales.</li>
<li>WideOpenWest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wow#NYSE">WOW</a>) shares fell 59.3% to $3.0050 following third-quarter results. Keybanc downgraded WideOpenWest from Overweight to Sector Weight.</li>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) shares declined 55% to $6.16 after the company reported downbeat sales results for the third quarter.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) shares dipped 53.9% to $0.42 after the company announced a public offering of 4,444,444 ordinary shares at a price of $0.45 per share.</li>
<li>Acutus Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afib#NASDAQ">AFIB</a>) fell 46.6% to $0.2500 following quarterly results.</li>
<li>Assertio Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asrt#NASDAQ">ASRT</a>) fell 46.2% to $1.14 after the company reported worse-than-expected third-quarter financial results.</li>
<li>James River Group Holdings, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jrvr#NASDAQ">JRVR</a>) dipped 35.8% to $8.44. James River Group recently reported worse-than-expected third-quarter revenue results.</li>
<li>NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) shares fell 32.5% to $2.0907 after the company reported weak quarterly sales.</li>
<li>Fossil Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fosl#NASDAQ">FOSL</a>) fell 31.1% to $1.1915 following third-quarter results.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) declined 29% to $0.9771. The company recently announced Family Medicine Specialists selected the company&#39;s epigenetic-genetic tests to identify patients at risk for coronary heart disease.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) fell 26.8% to $13.17 after the company reported worse-than-expected third-quarter financial results.</li>
<li>ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) declined 25.5% to $13.16 following third-quarter financial results.</li>
<li>Inspired Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inse#NASDAQ">INSE</a>) fell 25.3% to $7.77. Inspired said it requires additional time to complete financial statements for the third quarter and restate certain previously issued financial statements.</li>
<li>Cyngn Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NYSE">CYN</a>) fell 24.7% to $0.1994 following weak sales.</li>
<li>Traeger, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cook#NYSE">COOK</a>) declined 22.2% to $2.2950 following quarterly earnings.</li>
<li>Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) fell 22% to $0.5352 following quarterly results.</li>
<li>FREYR Battery (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frey#NYSE">FREY</a>) declined 21.3% to $2.6350 after reporting quarterly earnings.</li>
<li>GoodRx Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdrx#NASDAQ">GDRX</a>) fell 16% to $4.5597 following third-quarter results.</li>
<li>Royalty Management Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmco#NASDAQ">RMCO</a>) dipped 16% to $6.79.</li>
<li>Topgolf Callaway Brands Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modg#NYSE">MODG</a>) fell 15.9% to $10.47 after the company reported mixed third-quarter financial results.</li>
<li>Cipher Mining Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cifr#NASDAQ">CIFR</a>) declined 15.4% to $3.02. Bitfury Group announced sale of 10 million shares of Cipher Mining common stock at a price of $2.95 per share and lock-up agreement for remaining holding.</li>
<li>BILL Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bill#NYSE">BILL</a>) shares fell 14.8% to $52.94. Bill Holdings is in advanced talks to acquire Melio Payments, Bloomberg reported, citing people with knowledge of the matter.</li>
<li>Phibro Animal Health Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pahc#NASDAQ">PAHC</a>) dipped 14% to $10.35 following weak results.</li>
<li>Genpact Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/g#NYSE">G</a>) dropped 13.8% to $29.93 following weak sales.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) fell 13.8% to $8.69 after the company reported quarterly financial results and announced a $350 million at-the-market offering.</li>
<li>Luminar Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lazr#NASDAQ">LAZR</a>) shares declined 13.2% to $3.1938 after the company reported mixed third-quarter financial results.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) declined 12.4% to $13.44 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) shares fell 12% to $1.3116 following a wider-than-expected quarterly loss.</li>
<li>Instacart (Maplebear Inc.) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cart#NASDAQ">CART</a>) fell 11.1% to $24.21 following third-quarter results.</li>
<li>HeartCore Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htcr#NASDAQ">HTCR</a>) shares fell 11% to $0.4724 after declining 7% on Wednesday.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) declined 8.9% to $12.24 following weak results.</li>
<li>Myriad Genetics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mygn#NASDAQ">MYGN</a>) shares declined 6.4% to $16.73 after announcing pricing of upsized offering of common stock.</li>
<li>Arm Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arm#NASDAQ">ARM</a>) fell 6.2% to $51.02 after the company reported second-quarter financial results and issued guidance.</li>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) shares declined 5% to $7.92 after posting weak quarterly sales.</li>
<li>CCC Intelligent Solutions Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccs#NASDAQ">CCCS</a>) shares declined 4.1% to $11.21. CCC Intelligent Solutions priced secondary offering of 65 million shares at $10.50 per share.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/11/35701311/ethereum-surpasses-1-900-following-jobless-claims-data-huobi-token-emerges-as-top-gainer"> Ethereum Surpasses $1,900 Following Jobless Claims Data; Huobi Token Emerges As Top Gainer</a>

AFIB

AFRM

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ASLE

ASRT

ASTR

ATRA

BILL

Bakkt Holdings, Inc. Class A Common Stock

BKKT

CART

CCCS

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CDLX

CFRX

CIFR

CLMT

COOK

DNUT

FOSL

FREY

GDRX

HNST

HTCR

IKNA

Intelligent Bio Solutions Inc. - Common Stock

INBS

INFN

INSE

JRVR

LAZR

MYGN

NVTA

PAHC

PUBM

RAMP

RIOT

RMCO

RVNC

SLGC

SNES

SPCE

TAST

Tempest Therapeutics, Inc. - Common Stock

TPST

WLDS

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today&rsquo;s session.
<ul>
<li>Virgin Galactic Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spce#NYSE">SPCE</a>) shares jumped 27.5% to $1.99 after the company reported better-than-expected third-quarter financial results.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) shares jumped 22.7% to $26.70 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>Infinera Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infn#NASDAQ">INFN</a>) surged 22.6% to $4.06 following preliminary third-quarter results..</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) jumped 22% to $10.43 on the heels of the company&#39;s quarterly results.</li>
<li>SomaLogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slgc#NASDAQ">SLGC</a>) climbed 21.3% to $2.4750 following strong quarterly results.</li>
<li>PubMatic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pubm#NASDAQ">PUBM</a>) shares gained 20.4% to $14.57 after the company reported better-than-expected third-quarter financial results.</li>
<li>LiveRamp Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ramp#NYSE">RAMP</a>) shares gained 19.4% to $35.83 after the company posted upbeat second-quarter results and issued strong sales forecast.</li>
<li>Braskem S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bak#NYSE">BAK</a>) shares climbed 17.8% to $8.28 after Valor Economico Reported that Abu Dhabi&#39;s Adnoc Made a new offer to acquire a stake in the Brazilian petrochemical producer. Braskem also reported results for the third quarter.</li>
<li>Calumet Specialty Products Partners, L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clmt#NASDAQ">CLMT</a>) shares gained 16.3% to $15.12 following third-quarter results.</li>
<li>Seritage Growth Properties (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/srg#NYSE">SRG</a>) rose 16.3% to $8.65 following third-quarter results.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) shares gained 16.1% to $11.94.</li>
<li>Duolingo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duol#NASDAQ">DUOL</a>) rose 16% to $194.10 after the company reported better-than-expected -quarter sales results and raised full year guidance.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) climbed 15.4% to $11.57 after the company reported better-than-expected third-quarter financial results.</li>
<li>Vertex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verx#NASDAQ">VERX</a>) rose 15.2% to $25.80 following upbeat results.</li>
<li>Viasat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vsat#NASDAQ">VSAT</a>) rose 15.2% to $20.44 after the company reported better-than-expected second-quarter financial results.</li>
<li>Natera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntra#NASDAQ">NTRA</a>) climbed 14.6% to $47.40 following strong sales.</li>
<li>Jackson Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jxn#NYSE">JXN</a>) surged 14.4% to $44.55 following strong earnings.</li>
<li>Prospect Capital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psec#NASDAQ">PSEC</a>) gained 12.6% to $5.95 following upbeat sales.</li>
<li>Amphastar Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amph#NASDAQ">AMPH</a>) rose 12.1% to $50.92 following upbeat results.</li>
<li>Carrols Restaurant Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tast#NASDAQ">TAST</a>) surged 10.8% to $6.90 after the company reported better-than-expected third-quarter financial results.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) climbed 10.4% to $523.60.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) rose 9.4% to $96.66.</li>
<li>TransDigm Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdg#NYSE">TDG</a>) gained 9.2% to $977.69 after the company reported better-than-expected fourth-quarter financial results and issued FY24 sales guidance above estimates.</li>
<li>Paycor HCM, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pycr#NASDAQ">PYCR</a>) climbed 8.4% to $19.36 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>ACI Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aciw#NASDAQ">ACIW</a>) surged 7.5% to $26.28. ACI Worldwide will replace NextGen Healthcare in the S&amp;P SmallCap 600 effective prior to the opening of trading on Nov. 13.</li>
<li>The Walt Disney Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) shares gained 6.2% to $89.74 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Tapestry, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpr#NYSE">TPR</a>) rose 6.2% to $29.17 following upbeat earnings.</li>
<li>Twilio Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) gained 4.9% to $58.54 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/11/35701311/ethereum-surpasses-1-900-following-jobless-claims-data-huobi-token-emerges-as-top-gainer"> Ethereum Surpasses $1,900 Following Jobless Claims Data; Huobi Token Emerges As Top Gainer</a>

ACIW

AMPH

COIN

DUOL

MSTR

NTRA

PSEC

PYCR

TWLO

VERX

VSAT

Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday

Braskem SA (BAK) has released an update. Braskem S.A., a leading chemical company, has filed its September 2024 report with the SEC, indicating its...

Braskem S.A. Files SEC Report Amid Market Challenges

Braskem SA (BAK) has released an update. Braskem SA, a prominent player in the petrochemical industry, has submitted its Form 6-K report for Septem...

Braskem SA Submits SEC Filing for September 2024

Braskem Q2: Mixed Results, Cheap Valuation

Braskem SA (BAK) has released an update. Braskem S.A. has announced a change in its Board of Directors with the scheduled replacement of a member a...

Braskem S.A. Announces Board Member Change

Braskem SA (BAK) has released an update. Braskem S.A. calls for shareholder engagement in its exclusively digital Extraordinary General Meeting (EG...

Braskem S.A. Announces Digital EGM for Corporate Governance

Braskem SA (BAK) has released an update. Braskem S.A. has announced an Extraordinary General Meeting for shareholders to be held digitally on Octob...

Braskem S.A. Calls for Digital Extraordinary General Meeting

Braskem SA (BAK) has released an update. Braskem S.A. has publicly responded to the Securities and Exchange Commission of Brazil, clarifying that i...

Braskem Clarifies Stake Sale Rumors

Braskem raised to Buy at UBS on limited downside, potentially better pricing

Warning: BAK is at high risk of performing badly

Braskem SA (BAK) has released an update. Braskem SA announces that Brazil's Executive Management Committee of the Foreign Trade Chamber has approve...

Braskem SA Set to Gain from Import Tax Hike

Press Releases

Braskem Hosts 25th Red Cross Blood Drive in Partnership with the American Red Cross

Braskem Donates to the Mary M. Campbell Marcus Hook Public Library

Shell Chemicals and Braskem Bring Certified Bio-Attributed and Bio-Circular Propylene and Polypropylene to the U.S. Market

Commodities

Braskem posts Recurring EBITDA of US$211 million in the quarter, up 13% from 3Q23

Braskem posts Recurring EBITDA of US$230 million in the quarter, 9% higher than 4Q23 and 12% higher than 1Q23

Braskem Expands Its Fuels Business Portfolio With the Launch of Octane Plus

Braskem posts Recurring EBITDA of US$320 million in the quarter, 39% higher than 1Q24 and 128% higher than 2Q23

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Braskem

Braskem (BAK) Forecast

Braskem (NYSE:BAK) Stock, Quote.Headers.trade-ideas